- Home
- Products
Xospata (Gilteritinib)
Xospata (Gilteritinib)
- Medicine Name: Xospata
- Generic Name: Gilteritinib
- Dosage Form & Strength: Tablets – 40 mg
- Manufactured By: Astellas Pharma US, Inc.
Xospata is a kinase inhibitor approved for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) that carries a FLT3 mutation.
Recommended Dosage:
- 120 mg orally once daily, with or without food
- Do not break, chew, or crush tablets
- Treatment duration: minimum 6 months unless progression or unacceptable toxicity occurs
- Resume missed doses if taken at least 12 hours before the next scheduled dose
Interstitial Lung Disease (ILD)/Pneumonitis: Can be fatal. Monitor for respiratory symptoms and promptly assess any new/worsening cough, dyspnea, or fever.
Liver Toxicity: Monitor liver enzymes (ALT, AST, bilirubin) before and regularly during treatment. Interrupt dose if elevated.
Fetal Harm Risk: May harm an unborn baby. Use effective contraception during treatment and for 1 week after the last dose.
Breastfeeding: Not recommended during and for 1 week after final dose due to potential risk to the infant.
Drug Interactions: Inform your doctor of all other medications, including OTC and herbal supplements.
Required for Import:
- Valid prescription
- Diagnostic confirmation of FLT3 mutation
- Government-issued ID
Availability:
Xospata is available for import across India, including in Ahmedabad, Hyderabad, Pune, Delhi, and Chennai.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds imports Xospata through authorized global supply partners, with secure pharmacist-verified delivery through our Ambernath-based licensed fulfillment center.
Q: What is the generic name of Xospata®?
A: Gilteritinib
Q: Who manufactures Xospata®?
A: Astellas Pharma US, Inc.
Q: What is Xospata® used for?
A: Treatment of FLT3-mutated relapsed/refractory AML
Q: What is the dosage form?
A: Tablets – 40 mg for oral administration
Q: What are common side effects?
A: Fever, fatigue, nausea, diarrhea, elevated liver enzymes, rash, edema, dizziness
Q: Storage conditions?
A: Store at 20°C–25°C. Protect from light and humidity. Keep in original container until dispensed.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
